Janux Therapeutics JANX
NASDAQ JANX
$16.66 -0.40 (-2.34%)
At close: Oct 23, 2026 · 4:00 PM EDT

Janux Therapeutics (JANX) Sale and Maturity of Investments (2021 - 2026)

Updated

Analysis

Janux Therapeutics (JANX) Sale and Maturity of Investments (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Janux Therapeutics 1.02 Bn -2.87 Bn - 106.26 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 106.26 Mn
Mar 31, 2026 121.31 Mn
Dec 31, 2025 152.93 Mn
Sep 30, 2025 126.37 Mn
Jun 30, 2025 94.72 Mn
Mar 31, 2025 31.27 Mn
Dec 31, 2024 58.00 Mn
Sep 30, 2024 45.17 Mn
Jun 30, 2024 44.75 Mn
Mar 31, 2024 65.00 Mn
Dec 31, 2023 44.75 Mn
Sep 30, 2023 75.00 Mn
Jun 30, 2023 95.00 Mn
Mar 31, 2023 63.25 Mn
Dec 31, 2022 86.50 Mn
Sep 30, 2022 116.75 Mn
Jun 30, 2022 78.75 Mn
Mar 31, 2022 77.10 Mn
Dec 31, 2021 112.00 Mn
Sep 30, 2021 22.15 Mn
API Access

Janux Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=JANX&period=max&api_key=YOUR_API_KEY